Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Mental Health

Artificial Light at Night, Sleep Disruption, and Liver Health: Implications for MASLD Pathogenesis

Human epidemiological studies associate higher environmental ALAN exposure with obesity, metabolic syndrome, and poor sleep quality-recognized risk factors for MASLD.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This narrative review examines whether artificial light at night may affect liver and metabolic health, particularly fatty liver disease. The authors synthesize animal and human studies and report that blue-enriched light suppresses melatonin, disrupts circadian clocks, and is associated with insulin resistance and hepatic steatosis. The review is narrative, and the abstract does not report a pooled sample size.

Who or what was studied
Experimental animal models and human observational studies of nocturnal light exposure and liver or metabolic outcomes
Wavelengths
460, 480 nm
Limits stated in the abstract
The review is narrative rather than systematic, and the abstract does not state the number of included studies or participants.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

This narrative review explores the role of artificial light at night (ALAN) as an emerging environmental determinant of liver and metabolic health, with particular emphasis on its contribution to metabolic dysfunction-associated steatotic liver disease (MASLD). The objective was to synthesize and critically evaluate experimental and epidemiological evidence linking nocturnal light exposure, circadian disruption, and hepatic metabolic alterations. Literature was retrieved from PubMed, Scopus, Web of Science, and Google Scholar databases covering the period 1980-2025 using predefined search terms related to ALAN, circadian rhythm disturbance, melatonin suppression, sleep disruption, and MASLD. Relevant experimental studies in animal models and observational studies in humans were included. Evidence indicates that blue-enriched light (~460-480 nm) suppresses melatonin, desynchronizes central and hepatic circadian clocks, and disrupts glucose-lipid metabolism, leading to insulin resistance, oxidative stress, and hepatic steatosis. Chronic ALAN exposure also alters gut microbiota composition and increases intestinal permeability, suggesting a light-gut-liver axis in MASLD pathogenesis. Human epidemiological studies associate higher environmental ALAN exposure with obesity, metabolic syndrome, and poor sleep quality-recognized risk factors for MASLD. Recognizing ALAN as a modifiable environmental exposure highlights the need for public health strategies and clinical guidelines to mitigate its metabolic impact through improved lighting design and sleep hygiene.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
460-480 nm

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Oxidative stress. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies